Circulating angiogenic factor shows PAH biomarker potential
Hepatoma-derived growth factor predicts disease severity and survival in patients with pulmonary arterial hypertension, showing some possible clinical advantages over N-terminal pro-brain natriuretic peptide, researchers report.
Source: MedWire News - Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news
More News: Brain | Health | Hepatocellular Carcinoma | Hypertension | Liver Cancer | Neurology | Pulmonary Hypertension